hit counter

antidepressants

Long-Term Antidepressant (SSRI) Use Increasing: Overprescription & Withdrawal Hesitancy

by

The rise in antidepressant prescribing, especially selective serotonin reuptake inhibitors (SSRIs) since the 1980s, is a complex phenomenon with broad implications for public health. While these medications are crucial for many, the increase in long-term use has raised concerns about overprescription, side effects, and withdrawal challenges. Key Facts: Rising Prescriptions: Antidepressant prescriptions, particularly SSRIs, have …

Read more

Top 12 Antidepressant Nutrients & Foods for Depression Treatment

by

Depression is a growing public health concern, but nutrition may offer a pathway for prevention and treatment. A new research study identified the most nutrient-dense foods for brain health to inform dietary recommendations. Key Facts: 12 nutrients have evidence supporting a role in preventing and treating depression, including omega-3s, B vitamins, minerals like magnesium, and …

Read more

30+ New Antidepressants (2018): Drugs In Clinical Trials

by

Research suggests that upwards of 16 million American adults (6.7% of the adult population) are afflicted with major depressive disorder (MDD), a neuropsychiatric condition characterized by overwhelming sadness, behavioral changes, sleep disturbances, and cognitive deficits.  As of current, depression is the leading cause of disability in the United States among individuals between the ages of …

Read more

Intermittent Explosive Disorder (IED): Causes, Symptoms, Treatment

by

Intermittent explosive disorder (IED) is regarded as a subtype of impulse control disorder characterized by impulsive, uncontrollable explosive outbursts of anger, aggression, and/or rage – sometimes accompanied by violence.  To be considered intermittent explosive disorder, the explosive outbursts of anger must be triggered in situations and/or conditions in which such anger is unjustified.  In other …

Read more

Antidepressant Trials May Exclude Over 82% of People with Depression

by

A recent publication in the Journal of Psychiatric Practice documented that nearly 4/5 individuals diagnosed with major depression are considered ineligible to participate in clinical trials for new antidepressant drugs.  This means that for every 5 individuals with depression that attempt to join an antidepressant clinical trial, only one will meet inclusion criteria for registration.  …

Read more